Literature DB >> 10461297

Single center experience with femoral extraction of permanent endocardial pacing leads.

M Jarwe1, D Klug, J P Beregi, P Le Franc, D Lacroix, C Kouakam, L Guédon-Moreau, N Zghal, S Kacet.   

Abstract

Between March 1995 and June 1997, 128 leads were extracted from the hearts of 28 women and 50 men, 69 +/- 15 years of age (mean +/- SD, range 22-92 years). The indications for the procedure were: Accufix leads in 18 patients (14%), dysfunction or incompatibility with ICD in 16 (12%), endocarditis on the lead in 41 (32%), pulse generator pocket infection in 28 (22%), and pulse generator and/or lead erosion in 25 patients (19%). The extraction was performed with a snare (lasso), via a femoral vein as a first approach in 116 leads, and as an alternate approach, after extraction from the original site of implantation had failed, in 12 leads. The leads had been implanted for 62 +/- 48 months (range 1-205 months). A Cook sheath was used in 7, and a femoral approach traction in 20 instances. Of the 128 leads, 122 (95%) were completely extracted, and 2 (2%) were partially extracted (the distal electrode remaining attached to the myocardium), and 4 (3%) could not be removed. Four complications occurred: 2 tears of the tricuspid valve without clinical consequences, one separation of the lead's distal electrode which migrated into the hypogastric vein, and one hemorrhage at the femoral puncture site. There was no death or serious complication caused by lead extraction in this series.

Entities:  

Mesh:

Year:  1999        PMID: 10461297     DOI: 10.1111/j.1540-8159.1999.tb00601.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  Local symptoms at the site of pacemaker implantation indicate latent systemic infection.

Authors:  D Klug; F Wallet; D Lacroix; C Marquié; C Kouakam; S Kacet; R Courcol
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 2.  [ICD lead defects: diagnosis and therapeutical options].

Authors:  Christian G Wollmann; Dirk Böcker; Andreas Löher; Hans H Scheld; Günter Breithardt; Rainer Gradaus
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-02-11

Review 3.  Extraction of implantable cardiac electronic devices.

Authors:  John Rickard; Bruce L Wilkoff
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

4.  Reuse of occluded veins during permanent pacemaker lead extraction: a new indication for femoral lead extraction.

Authors:  Andrew D Staniforth; Richard J Schilling
Journal:  Indian Pacing Electrophysiol J       Date:  2002-10-01

5.  Transvenous Lead Extraction via the Inferior Approach Using a Gooseneck Snare versus Simple Manual Traction.

Authors:  Uk Jo; Jun Kim; You-Mi Hwang; Ji-Hyun Lee; Min-Su Kim; Hyung-Oh Choi; Woo-Seok Lee; Chang-Hee Kwon; Gi-Young Ko; Hyun-Ki Yoon; Gi-Byoung Nam; Kee-Joon Choi; You-Ho Kim
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

6.  Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads.

Authors:  Maria Grazia Bongiorni; Ezio Soldati; Giulio Zucchelli; Andrea Di Cori; Luca Segreti; Raffaele De Lucia; Gianluca Solarino; Alberto Balbarini; Mario Marzilli; Mario Mariani
Journal:  Eur Heart J       Date:  2008-10-23       Impact factor: 29.983

7.  One step behind to step ahead - femoral approach to stabilize and to extract functional pacing lead to regain venous access.

Authors:  Aleksander Maciąg; Paweł Syska; Krzysztof Kuśmierski; Beata Broy; Maciej Sterliński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-09-16       Impact factor: 1.426

8.  Percutaneous extraction of transvenous permanent pacemaker/defibrillator leads.

Authors:  Stylianos Paraskevaidis; Dimitrios Konstantinou; Vassilios Vassilikos; Efstratios Theofilogiannakos; Lilian Mantziari; Athanasia Megarisiotou; Ioannis Galitsianos; Charalambos Karvounis
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.